Table 2.
Number and percentage of N. gonorrhoeae isolates testing susceptible, intermediate and resistant against cefixime, ceftriaxone, azithromycin, penicillin and ciprofloxacin, n = 261 for year 2014 and n = 276 for year 2015, *p-value < 0.05
| Susceptible | Intermediate | Resistant | ||||
|---|---|---|---|---|---|---|
| Number (percentage, %) | Number (percentage, %) | Number (percentage, %) | ||||
| 2014 | 2015 | 2014 | 2015 | 2014 | 2015 | |
| Cefixime | 256 (98.1) | 272 (98.6) | ∕ | ∕ | 5 (1.9) | 4 (1.4) |
| Ceftriaxone | 261 (100) | 276 (100) | ∕ | ∕ | 0 (0) | 0 (0) |
| Azithromycin | 142 (54.4) | 171 (62.0) | 88 (33.7) | 78 (28.3) | 31 (11.9) | 27 (9.8) |
| Ciprofloxacin* | 73 (28.0) | 114 (41.3) | 0 (0) | 1 (0.4) | 188 (72.0) | 161 (58.3) |
| Penicillin* | 27 (10.3) | 40 (14.5) | 158 (60.5) | 184 (66.7) | 76 (29.1) | 52 (18.8) |